Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories.


Journal

Open biology
ISSN: 2046-2441
Titre abrégé: Open Biol
Pays: England
ID NLM: 101580419

Informations de publication

Date de publication:
01 2021
Historique:
entrez: 13 1 2021
pubmed: 14 1 2021
medline: 4 11 2021
Statut: ppublish

Résumé

Non-small-cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide. Although advances are being made towards earlier detection and the development of impactful targeted therapies and immunotherapies, the 5-year survival of patients with advanced disease is still below 20%. Effective cancer research relies on pre-clinical model systems that accurately reflect the evolutionary course of disease progression and mimic patient responses to therapy. Here, we review pre-clinical models, including genetically engineered mouse models and patient-derived materials, such as cell lines, primary cell cultures, explant cultures and xenografts, that are currently being used to interrogate NSCLC evolution from pre-invasive disease through locally invasive cancer to the metastatic colonization of distant organ sites.

Identifiants

pubmed: 33435818
doi: 10.1098/rsob.200247
pmc: PMC7881177
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

200247

Subventions

Organisme : Medical Research Council
ID : FC001169
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A27412
Pays : United Kingdom
Organisme : Cancer Research UK
ID : FC001169
Pays : United Kingdom
Organisme : Wellcome Trust
ID : FC001169
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 209199/Z/17/Z
Pays : United Kingdom

Références

Clin Cancer Res. 2011 Jan 1;17(1):134-41
pubmed: 21081655
Am J Clin Pathol. 1955 Oct;25(10):1107-12
pubmed: 13258519
Nat Commun. 2017 Feb 01;8:14381
pubmed: 28146145
Cell Stem Cell. 2020 Dec 3;27(6):905-919.e10
pubmed: 33142113
Nature. 2018 Feb 22;554(7693):544-548
pubmed: 29443960
Nature. 2019 May;569(7757):503-508
pubmed: 31068700
Cell Death Dis. 2018 Feb 7;9(2):177
pubmed: 29415996
Nat Biotechnol. 2019 Mar;37(3):314-322
pubmed: 30778230
Cancer Res. 2005 Nov 15;65(22):10280-8
pubmed: 16288016
Nat Biotechnol. 2021 Jan;39(1):64-73
pubmed: 32719479
Toxicol In Vitro. 2018 Mar;47:137-146
pubmed: 29155131
Cancer Prev Res (Phila). 2012 Feb;5(2):283-9
pubmed: 22086679
Exp Cell Res. 1997 Aug 25;235(1):245-53
pubmed: 9281374
Nature. 2019 Jul;571(7766):570-575
pubmed: 31243362
Mol Cancer Res. 2013 Jun;11(6):638-50
pubmed: 23449933
Clin Cancer Res. 2003 Sep 15;9(11):4227-39
pubmed: 14519650
PLoS One. 2015 Apr 10;10(4):e0122823
pubmed: 25860262
Am J Pathol. 1991 Aug;139(2):413-22
pubmed: 1651059
Nat Biotechnol. 2010 Jun;28(6):585-93
pubmed: 20495549
Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21727-21731
pubmed: 31591243
Nat Methods. 2017 Jul;14(7):737-742
pubmed: 28530655
Cell Rep. 2017 Oct 10;21(2):508-516
pubmed: 29020635
Am J Respir Crit Care Med. 2017 Jun 1;195(11):1494-1508
pubmed: 28199128
Am J Respir Cell Mol Biol. 2014 Apr;50(4):767-76
pubmed: 24191670
Cancer Res. 1987 Oct 1;47(19):5132-40
pubmed: 3621199
J Natl Cancer Inst. 2010 Sep 8;102(17):1310-21
pubmed: 20679594
N Engl J Med. 2017 Jun 1;376(22):2109-2121
pubmed: 28445112
Cell Stem Cell. 2020 Apr 2;26(4):482-502
pubmed: 32243808
Nat Commun. 2015 Feb 27;6:6169
pubmed: 25721094
Oncoimmunology. 2019 Aug 15;8(11):e1648170
pubmed: 31646094
Cancer Res. 2017 Apr 15;77(8):2029-2039
pubmed: 28202521
Cancer Res. 1978 Jul;38(7):2084-90
pubmed: 418873
Nature. 2011 May 5;473(7345):101-4
pubmed: 21471965
Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7160-5
pubmed: 21474781
Cell Rep. 2015 Jan 13;10(2):239-52
pubmed: 25558064
Development. 2017 Mar 1;144(5):755-766
pubmed: 28246210
Cell Rep. 2020 May 5;31(5):107588
pubmed: 32375033
Am J Respir Cell Mol Biol. 2012 Mar;46(3):269-82
pubmed: 22180870
Nature. 2014 Jul 31;511(7511):543-50
pubmed: 25079552
Nature. 2017 May 18;545(7654):355-359
pubmed: 28489818
Nature. 2007 Aug 16;448(7155):807-10
pubmed: 17676035
EMBO J. 2019 Feb 15;38(4):
pubmed: 30643021
Cancer Res. 1955 Jan;15(1):38-51
pubmed: 13231073
Cell. 2018 Feb 8;172(4):841-856.e16
pubmed: 29395328
Cancer Res. 2014 May 1;74(9):2377-84
pubmed: 24717177
J Immunol. 2004 Mar 1;172(5):2731-8
pubmed: 14978070
Am J Respir Cell Mol Biol. 2018 Aug;59(2):237-245
pubmed: 29447458
Cancer Treat Rep. 1977 Nov;61(8):1459-70
pubmed: 922751
Nature. 2001 Apr 26;410(6832):1111-6
pubmed: 11323676
Blood. 2005 Sep 1;106(5):1565-73
pubmed: 15920010
J Thorac Oncol. 2017 Feb;12(2):397-402
pubmed: 27507192
Cancer. 1951 Sep;4(5):1015-24
pubmed: 14879368
Clin Cancer Res. 2020 Jul 1;26(13):3431-3442
pubmed: 32209571
Proc Natl Acad Sci U S A. 2010 May 4;107(18):8352-6
pubmed: 20404174
Cancer Cell. 2016 Oct 10;30(4):519-532
pubmed: 27728803
Nat Med. 2019 Mar;25(3):517-525
pubmed: 30664780
N Engl J Med. 2016 Nov 10;375(19):1823-1833
pubmed: 27718847
Am J Physiol Lung Cell Mol Physiol. 2019 Sep 1;317(3):L424-L430
pubmed: 31364371
Cancer Discov. 2020 Oct;10(10):1489-1499
pubmed: 32690541
Cancer Treat Rev. 2018 Apr;65:1-10
pubmed: 29477930
Cancer Res. 2007 Oct 15;67(20):10027-37
pubmed: 17942937
Ann Thorac Surg. 1996 Jul;62(1):246-50
pubmed: 8678651
Curr Opin Genet Dev. 2019 Feb;54:88-96
pubmed: 31078083
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6409-E6417
pubmed: 27702896
Lab Invest. 1962 Aug;11:638-52
pubmed: 14490970
PLoS One. 2018 May 17;13(5):e0197129
pubmed: 29771943
PLoS One. 2010 Jun 10;5(6):e11022
pubmed: 20548776
Int J Cancer. 2018 Jul 1;143(1):160-166
pubmed: 29569246
Nat Rev Cancer. 2014 Aug;14(8):535-46
pubmed: 25056707
Cancer Cell. 2015 May 11;27(5):698-711
pubmed: 25936644
Nat Commun. 2018 Aug 10;9(1):3196
pubmed: 30097571
Genes Dev. 2020 Aug 1;34(15-16):1017-1032
pubmed: 32747478
J Natl Cancer Inst. 1973 Nov;51(5):1417-23
pubmed: 4357758
Am J Respir Cell Mol Biol. 2008 Nov;39(5):591-7
pubmed: 18539954
J Clin Invest. 2012 Mar;122(3):899-910
pubmed: 22293174
Cancer Prev Res (Phila). 2017 Sep;10(9):514-524
pubmed: 28754664
J Natl Cancer Inst. 1971 Sep;47(3):697-701
pubmed: 5157586
J Thorac Cardiovasc Surg. 2007 Feb;133(2):303-8
pubmed: 17258552
Nat Commun. 2019 Nov 29;10(1):5472
pubmed: 31784532
Eur J Cancer. 2016 Jul;62:132-7
pubmed: 27189322
Respir Investig. 2020 Sep;58(5):344-354
pubmed: 32586780
Cell. 2018 Sep 6;174(6):1586-1598.e12
pubmed: 30100188
Environ Res. 1997;74(2):150-8
pubmed: 9339228
Carcinogenesis. 2016 May;37(5):452-60
pubmed: 26964870
Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):4910-5
pubmed: 22411819
Clin Cancer Res. 1999 May;5(5):991-1000
pubmed: 10353731
Sci Transl Med. 2020 Jun 24;12(549):
pubmed: 32581131
Nature. 2020 Feb;578(7794):266-272
pubmed: 31996850
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4952-7
pubmed: 24586047
Cell Syst. 2020 Oct 21;11(4):393-401.e2
pubmed: 32937114
Nature. 2018 Mar 8;555(7695):251-255
pubmed: 29489752
Nat Rev Cancer. 2020 Mar;20(3):174-186
pubmed: 31980749
Am J Physiol. 1991 Aug;261(2 Pt 1):L70-6
pubmed: 1872417
Int J Cancer. 2017 Feb 1;140(3):662-673
pubmed: 27750381
Nature. 2015 Jun 18;522(7556):345-348
pubmed: 25822788
Cancer Sci. 2013 Dec;104(12):1560-6
pubmed: 24106881
PLoS One. 2013 Nov 11;8(11):e78823
pubmed: 24244370
Cancer Cell. 2003 Aug;4(2):111-20
pubmed: 12957286
Cancer Prev Res (Phila). 2019 Aug;12(8):507-516
pubmed: 31101634
Sci Rep. 2017 Jul 27;7(1):6689
pubmed: 28751748
J Clin Oncol. 2011 Apr 20;29(12):1556-63
pubmed: 21422424
J Thorac Oncol. 2016 Mar;11(3):287-99
pubmed: 26723239
Cell Rep. 2017 Dec 12;21(11):3298-3309
pubmed: 29241554
Int J Cancer. 2018 Jul 1;143(1):88-99
pubmed: 29341112
Ann Oncol. 2016 Jun;27(6):1155-1160
pubmed: 27013395
Dis Model Mech. 2019 Feb 12;12(2):
pubmed: 30760495
Adv Cancer Res. 1975;21:1-58
pubmed: 1108612
Cancers (Basel). 2018 Mar 14;10(3):
pubmed: 29538329
Nat Cancer. 2020 Mar;1(3):359-369
pubmed: 33345196
Cancer Res. 2018 Sep 1;78(17):5124-5134
pubmed: 29986997
Nat Med. 2016 Mar;22(3):262-9
pubmed: 26828195
Nat Commun. 2014 Mar 25;5:3472
pubmed: 24668028
Cancer Cell. 2020 Aug 10;38(2):212-228.e13
pubmed: 32707078
Clin Cancer Res. 2010 Mar 1;16(5):1442-51
pubmed: 20179238
Cell. 2020 May 14;181(4):848-864.e18
pubmed: 32298651
Dis Model Mech. 2017 Sep 1;10(9):1061-1074
pubmed: 28883015
Am J Respir Cell Mol Biol. 2020 Jun;62(6):681-691
pubmed: 31991090
J Clin Oncol. 2008 Jul 20;26(21):3552-9
pubmed: 18506026
Carcinogenesis. 1997 Mar;18(3):575-86
pubmed: 9067559
Methods Mol Biol. 2019;1953:241-252
pubmed: 30912026
Nat Rev Drug Discov. 2020 Aug;19(8):533-552
pubmed: 32528145
Nat Commun. 2019 Apr 23;10(1):1856
pubmed: 31015447
Nat Med. 2018 Aug;24(8):1277-1289
pubmed: 29988129
Oncotarget. 2017 Mar 21;8(12):18885-18900
pubmed: 27935865
Toxicol Pathol. 1991;19(2):168-75
pubmed: 1771369
ACS Nano. 2015 Mar 24;9(3):2377-89
pubmed: 25703655
Genes Dev. 2001 Dec 15;15(24):3243-8
pubmed: 11751630
Neoplasia. 2015 Sep;17(9):735-741
pubmed: 26476081
Nature. 2012 Sep 27;489(7417):519-25
pubmed: 22960745
Nat Genet. 2018 Apr;50(4):483-486
pubmed: 29610476
Nature. 2015 Jan 22;517(7535):489-92
pubmed: 25363767
Cell Rep. 2020 May 5;31(5):107550
pubmed: 32375028
Nat Med. 2017 Mar;23(3):291-300
pubmed: 28191885
PLoS One. 2008 May 07;3(5):e2125
pubmed: 18461184
Nature. 2020 Dec;588(7839):670-675
pubmed: 33238290
JCO Precis Oncol. 2017;2017:
pubmed: 29333526
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
PLoS One. 2013;8(2):e56010
pubmed: 23418494
J Clin Oncol. 2019 Oct 1;37(28):2518-2527
pubmed: 31154919
Clin Cancer Res. 2015 Mar 1;21(5):1172-82
pubmed: 25549722
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19893-7
pubmed: 19064915
Nature. 2018 Aug;560(7718):325-330
pubmed: 30089904
J Clin Invest. 2013 Jul;123(7):3025-36
pubmed: 23921127
Br J Cancer Suppl. 1980 Apr;4:142-5
pubmed: 6252930
Oncotarget. 2017 Feb 14;8(7):11114-11126
pubmed: 28052041
Nat Commun. 2019 Sep 5;10(1):3991
pubmed: 31488816
Cancer Cell Int. 2019 Jan 29;19:21
pubmed: 30718976
Sci Rep. 2017 Nov 13;7(1):15454
pubmed: 29133824
Cancer Res. 1968 Jan;28(1):104-24
pubmed: 5635364
J Transl Med. 2016 Feb 29;14:61
pubmed: 26928703
Trends Cancer. 2020 Jul;6(7):569-579
pubmed: 32312681
Nat Rev Cancer. 2019 Mar;19(3):133-150
pubmed: 30755690
Respir Res. 2019 Aug 23;20(1):196
pubmed: 31443657
Genes Dev. 2006 Jun 1;20(11):1496-510
pubmed: 16705038
In Vitro. 1982 Jul;18(7):633-42
pubmed: 7141447
Nat Commun. 2017 Apr 07;8:14922
pubmed: 28387316
Science. 2010 Jun 25;328(5986):1662-8
pubmed: 20576885
Nat Med. 2015 Mar;21(3):256-62
pubmed: 25706875
Lung Cancer. 2019 Nov;137:113-122
pubmed: 31568888
FASEB J. 2018 Mar;32(3):1537-1549
pubmed: 29146734
Cancer Res. 2015 Dec 15;75(24):5378-91
pubmed: 26567140
Elife. 2019 May 29;8:
pubmed: 31140976
Br J Cancer. 2014 Sep 9;111(6):1021-46
pubmed: 25117809
Cancer Cell. 2020 Aug 10;38(2):229-246.e13
pubmed: 32707077
Cell Rep. 2014 Jul 10;8(1):40-9
pubmed: 24953650
Science. 2018 Mar 9;359(6380):1118-1123
pubmed: 29420258
Nat Commun. 2016 Jun 02;7:11739
pubmed: 27252083
Cancer Cell. 2011 Jan 18;19(1):72-85
pubmed: 21251614

Auteurs

Robert E Hynds (RE)

Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, University College London, London, UK.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.

Kristopher K Frese (KK)

Cancer Research UK Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK.
Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Alderley Park, Macclesfield, UK.

David R Pearce (DR)

Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, University College London, London, UK.

Eva Grönroos (E)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.

Caroline Dive (C)

Cancer Research UK Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK.
Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Alderley Park, Macclesfield, UK.

Charles Swanton (C)

Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, University College London, London, UK.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH